Eyetech Pharmaceuticals

About:

Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye.

Website: http://www.eyetk.com/

Top Investors: MPM Capital, JPMorgan Partners, Alta Partners, Merrill Lynch, BB Biotech Ventures

Description:

Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.

Total Funding Amount:

$109M

Headquarters Location:

New York, New York, United States

Founded Date:

1997-01-01

Founders:

Anthony P. Adamis, David Guyer, Marty Glick, Samir Patel

Number of Employees:

251-500

Last Funding Date:

2001-08-08

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai